[Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
The release of tissue-type plasminogen activator (t-PA) after venous occlusion was tested in 290 patients with venous thrombosis, at earliest three months after the last thrombo-embolic episode. In 37 patients (12.8%) the t-PA-activity was decreased. In 14 patients (4.8%) the defect was confirmed by control. A reduced release of t-PA was found in 4 patients, while 10 out of 14 patients had comparatively higher levels of plasminogen-activator-inhibitor (PAI-I).
Hach-Wunderle
V
V
Abteilung für Innere Medizin, William Harvey-Klinik, Bad Nauheim.
Scharrer
I
I
D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology*; D015849:Plasminogen Inactivators / Q000097:blood; D012016:Reference Values; D013924:Thrombophlebitis / Q000097:blood*; D010959:Tissue Plasminogen Activator / Q000097:blood*
D015849:Plasminogen Inactivators; D010959:Tissue Plasminogen Activator
Störungen der Freisetzung von Gewebe-Plasminogen-Aktivator (t-PA) aus der Venenwand als Ursache für rezidivierende Thrombosen.